Oxaprozin versus diclofenac in NSAID-refractory periarthritis pain of the shoulder

Current Medical Research and Opinion

Volumn 20, Issue 8, 2004, Pages 1279-1290

  Heller, Barbara ^a,c   Tarricone, Rosanna ^b  

^a Zenter für Klinische Studien   (Germany)

^b BOCCONI UNIVERSITY   (Italy)

^c NONE   (Germany)

Author keywords

Diclofenac; Health related quality of life (HRQL); Non steroidal anti inflammatory drugs; NSAIDs; Oxaprozin; Quality of life; Shoulder periarthritis

Indexed keywords

ANALGESIC AGENT; ANTIINFLAMMATORY AGENT; ANTIRHEUMATIC AGENT; CORTICOSTEROID; DICLOFENAC; IBUPROFEN; MUSCLE RELAXANT AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; OXAPROZIN;

ADULT; ARTICLE; BLOOD TOXICITY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; HYPOTHESIS; LIVER TOXICITY; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NEPHROTOXICITY; OPEN STUDY; PAIN ASSESSMENT; PERIARTHRITIS; QUALITY OF LIFE; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SHOULDER PAIN; SIDE EFFECT; TOOTH DISEASE; TREATMENT OUTCOME; VIRUS INFECTION;

EID: 4344610339     PISSN: 03007995     EISSN: None     Source Type: Journal    
DOI: 10.1185/030079904125004411     Document Type: Article

References (46)

1. Buckle P. Upper limb disorders and work: the importance of physical and psychosocial factors. J Psychosom Res 1997;43:17-25
2. Chipchase LS, O'Connor DA, Costi JJ, et al. Shoulder impingement syndrome: preoperative health status. J Shoulder Elbow Surg 2000;9:12-15
3. van der Windt PA, Thomas E, Pope DP, et al. Occupational risk factors for shoulder pain: a systematic review. Occup Environ Med 2000;57:433-42
4. Siegel LB, Cohen NJ, Gall EP. Adhesive capsulitis: a sticky issue. Am Fam Physician 1999;59:1843-52
5. Pope DP, Croft PR, Pritchard CM, et al. Prevalence of shoulder pain in the community: the influence of case-definition. Ann Rheum Dis 1997;56:308-12
6. Panel P. Philadelphia Panel Evidence-Based Clinical Practice Guidelines on Selected Rehabilitation Interventions for Shoulder Pain. Phys Ther 2001;81:1719-30
7. Pope DP, Croft PR, Pritchard CM, et al. Occupational factors related to shoulder pain and disability. Occup Environ Med 1997;54:316-21
8. Cagliero E, Apruzzese W, Perlmutter GS, et al. Musculoskeletal disorders of the hand and shoulder in patients with diabetes mellitus. Am J Med 2002;112:487-90
9. Lee M, Haq AM, Wright V, et al. Periarthritis of the shoulder: a controlled trial of physiotherapy. Physiotherapy 1973;59:312-5
10. Zancan A, Gialanella B, Luisa A, et al. Telethermographic effects and a comparative clinical assessment of the treatment of shoulder periarthritis using ultrasound. G Ital Med Lav 1993;15:55-8
11. Itokazu M, Matsunaga T. Clinical evaluation of high-molecular weight sodium hyaluronate for the treatment of patients with periarthritis of the shoulder. Clin Ther 1995;17:946-55
12. van der Windt DA, van der Heijden GJ, Scholten RJ, et al. The efficacy of non steroidal anti-inflammatory drugs (NSAIDs) for shoulder complaints. A systematic review. J Clin Epidemiol 1995;48:691-704
13. Miszczyk L, Walichiewicz P, Spindel J. Use of radiotherapy in treatment of painful scapula-humeral periarthritis. Chir Narzadow Ruchu Ortop Pol 2001;66:67-71
14. Jakobeit C, Winiarski B, Jakobeit S, et al. Ultrasound-guided, high-energy extracorporeal shock-wave treatment of symptomatic calcareous tendinopathy of the shoulder. Aust N Z J Surg 2002;72:496-500
15. Duke O, Zecler E, Grahame R. Anti-inflammatory drugs in periarthritis of the shoulder: a double blind, between patient study of naproxen versus indomethacin. Rheumatol Rehabil 1981;20:54-9
16. Rhind V, Downie WW Bird HA, et al. Naproxen and indomethacin in periarthritis of the shoulder. Rheumatol Rehabil 1982;21:51-3
17. Famaey JP, Ginsberg F. Treatment of periarthritis of the shoulder: a comparison of ibuprofen and diclofenac. J Int Med Res 1984;12:238-43
18. Mena HR, Lomen PL, Turner LF, et al. Treatment of acute shoulder syndrome with flurbiprofen. Am J Med 1986;80:141-4
19. Smith MD, Thomas D, McCredie M, et al. Piroxicam versus naproxen in treatment of the painful shoulder. Pharmatherapeutica 1986;4:585-9
20. Thumb N, Kolarz G, Scerak O, et al. The efficacy and safety of fentiazac and diclofenac sodium in peri-arthritis of the shoulder: a multi-center, double blind comparison. J Int Med Res 1987;15:327-34
21. Mili F, Helmick CG, Moriarty DG. Health related quality of life among adults reporting arthritis: analysis of data from the Behavioral Risk Factor Surveillance System, US, 1996-99. J Rheumatol 2003;30:160-6
22. Ginsberg F, Famaey JP. A double-blind, parallel trial of oxaprozin versus naproxen in the treatment of osteoarthritis. Curr Med Res Opin 1984;8:689-95
23. Weaver A, Bernard R, Caldwell J, et al. Comparison of the efficacy and safety of oxaprozin and nabumetone in the treatment of patients with osteoarthritis of the knee. Clin Ther 1995;17:735-45
24. Makarowski W, Weaver A, Rubin B, et al. The efficacy, tolerability, and safety of 1200 mg/d of oxaprozin and 1500 mg/d nabumetone in the treatment of patients with osteoarthritis of the knee. Clin Ther 1996;18:114-24
25. Karbowski A, Schwitalle M, Eckardt A. Oxaprozin versus diclofenac retard in treated of activated osteoarthrosis. Z Rheumatol 1998;57:108-13
26. Zhao SZ, Dedhiya SD, Bocanegra TS, et al. Health-related quality-of-life-effects of oxaprozin and nabumetone in patients with osteoarthritis of the knee. Clin Ther 1999;21:205-17
27. Petrella RJ, Bartha C. Home based exercise therapy for older patients with knee osteoarthritis: a randomized clinical trial. J Rheumatol 2000;27:2215-21
28. Jamar R, Dequeker J. Oxaprozin versus aspirin in rheumatoid arthritis: a double-blind trial. Curr Med Res Opin 1978;5:433-8
29. Hubsher JA, Ballard IM, Walker BR, et al. A multicentre double-blind comparison of oxaprozin aspirin therapy on rheumatoid arthritis. J Int Med Res 1979;7:69-76
30. Reynolds WJ, Shaar SF, Buik A, et al. Oxaprozin: a once-daily treatment regimen in rheumatoid arthritis. J Rheumatol 1979;6:345-50
31. Zuccollo R, McKinnon MJ, Fraser KM, et al. Oxaprozin and sulindac in rheumatoid arthritis: a double-blind comparative trial. Curr Med Res Opin 1983;8:302-9
32. Karbowski A, Schwitalle M, Eckardt A. Oxaprozin versus diclofenac in the treatment of rheumatoid arthritis. Aktuelle Rheumatologie 1998;23:11-5
33. Santo JE, Queiroz MV. Oxaprozin versus diclofenac sodium in the treatment of ankylosing spondylitis. J Int Med Res 1988;16:150-6
34. Bono RF, Finkel S, Goodman HE, et al. Oxaprozin in the treatment of patients with tendinitis and bursitis: comparison with phenylbutazone and placebo. Semin Arthritis Rheum 1986;15(Suppl 2):90-4
35. Todd PA, Brogden RN. Oxaprozin. A preliminary review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy. Drugs 1986;32:291-312
36. Miller LG. Oxaprozin: a once-daily nonsteroidal anti-inflammatory drug. Clin Pharm 1992;11:591-603. Comment in: Clin Pharm 1993;12:255-6
37. Miller LG. Oxaprozin: a once-daily nonsteroidal anti-inflammatory drug. Clin Pharm 1992;11:591-603. Comment in: Clin Pharm 1993;12:255-6
38. Kean WF, Kean R, Buchanan WW. A critical assessment of oxaprozin clinical profile in rheumatic diseases. Inflammopharmacology 2002;10:241-84
39. Ranieri M, Fiore P, Santamato A, et al. Use of oxaprozin in several rehabilitation-responsive pathologies: longitudinal observation in 40 patients. Giornale Italiano di Medicina Riabilitativa 2002;16:83-7
40. Paschina E, Zorzi F, Chemello P. Oxaprozin in the conservative treatment of the painful shoulder and in the post-operative pain after acromioplasty. Ortopedia e Traumatologia Sertot 2003;45:101-3
41. Ethgen O, Kahler KH, Kong SX, et al. The effect of health related quality of life on reported use of health care resources in patients with osteoarthritis and rheumatoid arthritis: a longitudinal analysis. J Rheumatol 2002;29:1147-55
42. Winters JC, Sobel JS, Groenier KH, et al. A shoulder pain score: a comprehensive questionnaire for assessing pain in patients with shoulder complaints. Scand J Rehabil Med 1996;28:163-7
43. Ware JEJ, Gandek B. Overview of the SF-36 Health Survey and the International Quality of Life Assessment (IQOLA) Project. J Clin Epidemiol 1998;51:903-12
44. Kosinski M, Keller SD, Hatoum HT, et al. The SF-36 Health Survey as a generic outcome measure in clinical trials of patients with osteoarthritis and rheumatoid arthritis: relative validity of scales in relation to clinical measures of arthritis severity. Med Care 1999;37(Suppl 5):MS23-39
45. Skevington SM, Carse MS, Williams AC. Validation of the WHOQOL-100: pain management improves quality of life for chronic pain patients. Clin J Pain 2001;17:264-75
46. Skoutakis VA, Carter CA, Mickle TR, et al. Review of diclofenac and evaluation of its place in therapy as a nonsteroidal anti-inflammatory agent. Drug Intell Clin Pharm 1988;22:850-9